Overall survival (OS) results from the phase 3 TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of physicianaEUR(tm)s choice (TPC) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC)
Sacituzumab Govitecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Overall survival (OS) results from the phase 3 TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of physicianaEUR(tm)s choice (TPC) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC) ### Output: Sacituzumab Govitecan